metronidazole has been researched along with Stroke in 5 studies
Metronidazole: A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.
metronidazole : A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death.
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
Excerpt | Relevance | Reference |
---|---|---|
" Through the Cockayne Syndrome Natural History Study, we have identified 8 cases of acute hepatic failure after metronidazole administration (8% of our cohort), 3 of which were fatal." | 7.81 | Metronidazole Toxicity in Cockayne Syndrome: A Case Series. ( Munkley, J; O'Kelly, S; Stark, Z; Strong, A; Wilson, BT, 2015) |
" Through the Cockayne Syndrome Natural History Study, we have identified 8 cases of acute hepatic failure after metronidazole administration (8% of our cohort), 3 of which were fatal." | 3.81 | Metronidazole Toxicity in Cockayne Syndrome: A Case Series. ( Munkley, J; O'Kelly, S; Stark, Z; Strong, A; Wilson, BT, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Liu, C | 2 |
Cheng, X | 1 |
Zhong, S | 1 |
Liu, Z | 1 |
Liu, F | 1 |
Lin, X | 1 |
Zhao, Y | 1 |
Guan, M | 1 |
Xiao, T | 1 |
Jolkkonen, J | 1 |
Wang, Y | 1 |
Zhao, C | 1 |
Takada, K | 1 |
Maki, Y | 1 |
Kinosada, M | 1 |
Ishibashi, R | 1 |
Chin, M | 1 |
Yamagata, S | 1 |
Wilson, BT | 1 |
Strong, A | 1 |
O'Kelly, S | 1 |
Munkley, J | 1 |
Stark, Z | 1 |
Aebischer, B | 1 |
Elsig, S | 1 |
Taeymans, J | 1 |
Pomp, S | 1 |
Kuhness, D | 1 |
Barcaro, G | 1 |
Sementa, L | 1 |
Mankad, V | 1 |
Fortunelli, A | 1 |
Sterrer, M | 1 |
Netzer, FP | 1 |
Surnev, S | 1 |
Schmieder, AH | 1 |
Caruthers, SD | 1 |
Keupp, J | 1 |
Wickline, SA | 1 |
Lanza, GM | 1 |
Lowe, J | 1 |
Wodarcyk, AJ | 1 |
Floyd, KT | 1 |
Rastogi, N | 1 |
Schultz, EJ | 1 |
Swager, SA | 1 |
Chadwick, JA | 1 |
Tran, T | 1 |
Raman, SV | 1 |
Janssen, PM | 1 |
Rafael-Fortney, JA | 1 |
Alcalay, RN | 1 |
Levy, OA | 1 |
Wolf, P | 1 |
Oliva, P | 1 |
Zhang, XK | 1 |
Waters, CH | 1 |
Fahn, S | 1 |
Kang, U | 1 |
Liong, C | 1 |
Ford, B | 1 |
Mazzoni, P | 1 |
Kuo, S | 1 |
Johnson, A | 1 |
Xiong, L | 1 |
Rouleau, GA | 1 |
Chung, W | 1 |
Marder, KS | 1 |
Gan-Or, Z | 1 |
Kamei, K | 1 |
Terao, T | 1 |
Katayama, Y | 1 |
Hatano, K | 1 |
Kodama, K | 1 |
Shirahama, M | 1 |
Sakai, A | 1 |
Hirakawa, H | 1 |
Mizokami, Y | 1 |
Shiotsuki, I | 1 |
Ishii, N | 1 |
Inoue, Y | 1 |
Akboga, MK | 1 |
Yayla, C | 1 |
Balci, KG | 1 |
Ozeke, O | 1 |
Maden, O | 1 |
Kisacik, H | 1 |
Temizhan, A | 1 |
Aydogdu, S | 1 |
Zhu, J | 2 |
Ying, SH | 1 |
Feng, MG | 1 |
Zhang, XG | 1 |
Li, H | 1 |
Wang, L | 1 |
Hao, YY | 1 |
Liang, GD | 1 |
Ma, YH | 1 |
Yang, GS | 1 |
Hu, JH | 1 |
Pfeifer, L | 1 |
Goertz, RS | 1 |
Neurath, MF | 1 |
Strobel, D | 1 |
Wildner, D | 1 |
Lin, JT | 1 |
Yang, XN | 1 |
Zhong, WZ | 1 |
Liao, RQ | 1 |
Dong, S | 1 |
Nie, Q | 1 |
Weng, SX | 1 |
Fang, XJ | 1 |
Zheng, JY | 1 |
Wu, YL | 1 |
Řezanka, T | 1 |
Kaineder, K | 1 |
Mezricky, D | 1 |
Řezanka, M | 1 |
Bišová, K | 1 |
Zachleder, V | 1 |
Vítová, M | 1 |
Rinker, JA | 1 |
Marshall, SA | 1 |
Mazzone, CM | 1 |
Lowery-Gionta, EG | 1 |
Gulati, V | 1 |
Pleil, KE | 1 |
Kash, TL | 1 |
Navarro, M | 1 |
Thiele, TE | 1 |
Zhang, Y | 1 |
Huang, Y | 1 |
Jin, Z | 1 |
Li, X | 1 |
Li, B | 1 |
Xu, P | 1 |
Huang, P | 1 |
Fokdal, L | 1 |
Sturdza, A | 1 |
Mazeron, R | 1 |
Haie-Meder, C | 1 |
Tan, LT | 1 |
Gillham, C | 1 |
Šegedin, B | 1 |
Jürgenliemk-Schultz, I | 1 |
Kirisits, C | 1 |
Hoskin, P | 1 |
Pötter, R | 1 |
Lindegaard, JC | 1 |
Tanderup, K | 1 |
Levin, DE | 1 |
Schmitz, AJ | 1 |
Hines, SM | 1 |
Hines, KJ | 1 |
Tucker, MJ | 1 |
Brewer, SH | 1 |
Fenlon, EE | 1 |
Álvarez-Pérez, S | 1 |
Blanco, JL | 1 |
Peláez, T | 1 |
Martínez-Nevado, E | 1 |
García, ME | 1 |
Puckerin, AA | 1 |
Chang, DD | 1 |
Subramanyam, P | 1 |
Colecraft, HM | 1 |
Dogan, H | 1 |
Coteli, E | 1 |
Karatas, F | 1 |
Ceylan, O | 1 |
Sahin, MD | 1 |
Akdamar, G | 1 |
Kryczyk, A | 1 |
Żmudzki, P | 1 |
Hubicka, U | 1 |
Giovannelli, D | 1 |
Chung, M | 1 |
Staley, J | 1 |
Starovoytov, V | 1 |
Le Bris, N | 1 |
Vetriani, C | 1 |
Chen, W | 1 |
Wu, L | 1 |
Liu, X | 1 |
Shen, Y | 1 |
Liang, Y | 1 |
Tan, H | 1 |
Yang, Y | 1 |
Liu, Q | 1 |
Wang, M | 1 |
Liu, L | 1 |
Wang, X | 1 |
Liu, B | 1 |
Liu, GH | 1 |
Zhu, YJ | 1 |
Wang, JP | 1 |
Che, JM | 1 |
Chen, QQ | 1 |
Chen, Z | 1 |
Maucksch, U | 1 |
Runge, R | 1 |
Wunderlich, G | 1 |
Freudenberg, R | 1 |
Naumann, A | 1 |
Kotzerke, J | 1 |
Song, HC | 1 |
Bom, HS | 1 |
Cho, KH | 1 |
Kim, BC | 1 |
Seo, JJ | 1 |
Kim, CG | 1 |
Yang, DJ | 1 |
Kim, EE | 1 |
1 review available for metronidazole and Stroke
Article | Year |
---|---|
Topics: AC133 Antigen; Acenaphthenes; Acer; Acrosome Reaction; Adult; Agaricales; Aged; Aged, 80 and over; A | 2016 |
1 trial available for metronidazole and Stroke
Article | Year |
---|---|
Prognostication of recovery in patients with acute ischemic stroke through the use of brain SPECT with Technetium-99m--labeled metronidazole.
Topics: Acute Disease; Aged; Brain; Brain Ischemia; Cysteine; Diffusion Magnetic Resonance Imaging; Female; | 2003 |
3 other studies available for metronidazole and Stroke
Article | Year |
---|---|
Long-term modification of gut microbiota by broad-spectrum antibiotics improves stroke outcome in rats.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Cytokines; Endothelin-1; Fatty Acids, Vol | 2022 |
Metronidazole Induced Encephalopathy Mimicking an Acute Ischemic Stroke Event.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Brain Ischemia; Diagnosis, Differential; Female; Humans; M | 2018 |
Metronidazole Toxicity in Cockayne Syndrome: A Case Series.
Topics: Adolescent; Anti-Infective Agents; Cockayne Syndrome; Fatal Outcome; Female; Gastrointestinal Diseas | 2015 |